Picture of Medpace Holdings logo

01P Medpace Holdings News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Medpace Holdings Inc expected to post earnings of $1.26 a share - Earnings Preview

* Medpace Holdings Inc  MEDP.OQ   MEDP.O  is expected
to show a
rise in quarterly revenue when it reports  results on April 25. 
    * The Cincinnati Ohio-based  company is expected to report 
a
25.8% increase in revenue to $327.094 million from $259.97
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Medpace Holdings
Inc is
for earnings of $1.26 per share. For the same quarter last year,
the company reported earnings of $1.14 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Medpace
Holdings
Inc is $160​, above​ its last closing price of $150.62. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  1.25        1.25       1.32      Beat    5.5
 Sep. 30 2021  1.08        1.07       1.29      Beat    20.1
 Jun. 30 2021  0.99        0.99       1.06      Beat    7.1​
 Mar. 31 2021  1.00        1.00       1.14      Beat    13.6
 ​​Dec.        1.23        1.24       1.35      Beat    8.8
 31 2020                                                
 Sep. 30 2020  1.09        1.07       1.09      Beat    1.5​
 Jun. 30 2020  0.44        0.41       0.68      Beat    64.4
 Mar. 31 2020  0.75        0.75       0.80      Beat    7
 This summary was machine generated April 23 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Medpace Holdings

See all news